| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |